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ABSTRACT. Synthetic polymers have had a major impact on the biomedical field. However, all 
polymers have their advantages and disadvantages, so that the selection of a certain polymeric material 
always is a compromise with regard to many properties, such as synthetic accessibility, solubility, thermal 
properties, biocompatibility and degradability. The development of novel polymers with superior 
properties for medical applications is the focus of many research groups. The present study highlights the 
use of poly(2-isopropenyl-2-oxazoline) (PiPOx), as biocompatible functional polymer to develop 
synthetic hydrogel materials using a simple straightforward synthesis protocol. A library of hydrogels was 
obtained by chemical cross-linking of PiPOx, using eight different non-toxic and bio-based dicarboxylic 
acids. The equilibrium swelling degree (ESD) of the final material can be modulated by simple 
modification of the composition of the reaction mixture, including the polymer concentration in the feed 
ratio between the 2-oxazoline pendent groups and the carboxylic acid groups as well as the cross-linker 
2 
 
length. The hydrogels with the highest water uptake were selected for further investigations regarding 
their potential use as biomaterials. We evaluated the thermoresponsiveness, the pH-degradability under 
physiological conditions and demonstrated proof-of-concept drug delivery experiments. The in vitro 
cellular studies demonstrated the noncytotoxic character of the PiPOx hydrogels, and its protein repellent 
properties, while mineralization studies revealed that such scaffolds do not promote 
mineralization/calcification phenomena. In view, of these results, these hydrogels show potential use as 
ophthalmologic materials or in drug delivery applications. 
 
Keywords: poly(2-isopropenyl-2-oxazoline), hydrogels, pH degradability, thermoresponsive 
hydrogels 
 
1. INTRODUCTION 
 
 Over the past decades, polymer chemists have designed a wide range of synthetic biomaterials to 
be used in biomedical applications, and one particular class of biomaterials that has been the subject of 
intense research are hydrogels as they resemble natural materials, such as the extracellular matrix and the 
interior of cells.1-6 To date, extensive studies have been directed towards the development of synthetic 
hydrogels for wound dressing,7-9 tissue engineering,10-13 ophthalmology14, 15 and drug delivery.16-20 
Hydrogels are three-dimensional networks formed from hydrophilic homopolymers, copolymers, or 
macromers cross-linked to form water-insoluble polymer matrices.21 The hydrogels prepared via chemical 
cross-linking from synthetic hydrophilic monomers or polymers are often preferred over natural polymers 
due to their structural versatility, reproducibility of synthesis, controlled structure and improved 
mechanical properties.1, 22-24 However the biocompatibility and biodegradability represent some major 
problems that still need to be tackled, especially in the case of implantable hydrogels. The majority of 
studies on synthetic polymer hydrogels are based on the use of poly(ethylene glycol)s (PEG),20, 24 
poly(vinylpyrrolidone) (PVP),25-27 poly(vinyl alcohol) (PVA),28-30 poly(hydroxyethyl methacrylate) 
(PHEMA),19, 31-34 and more recently poly(2-oxazoline)s (PAOx).18, 35-37 Although, these polymers have 
certain advantages they all come hand in hand with shortcomings that can limit their applicability as 
biomaterials. PEG has been the most commonly used water-soluble biomaterial for biomedical 
applications, because of the commercial availability in a wide range of molecular weights together with 
its hydrophilicity, solubility, biocompatibility, and reduced protein adsorption.38 However recent reports 
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have shown that PEG can be nephro- and hepatotoxic, immunogenic with an incidence of allergy being 
present in a quarter of the population.39 Other concerns are the nonbiodegradable nature and the 
susceptibility to oxidative degradation that generates toxic products for the living tissues.38 PEG hydrogels 
are often designed from macromers with reactive end-chain functionalities, that allow limited covalent 
cross-linking loci.20 The chemical identity of the macromer and the mechanism of hydrogel formation are 
both important as each influences the cross-linking density of the hydrogel network and thus, dictates the 
value of the elastic modulus and the mesh structure.24 PVP is widely used in the development of hydrogel 
based-biomaterials, because it does not generally elicit an immune response,27 unlike poly(N-isopropyl 
acrylamide) (PNIPAM).40 However, potential disadvantages of PVP hydrogels include allergic reactions 
due to activation of suppressor T cells,41 nonbiodegradability, hygroscopicity42 and suppression of 
fertilization.43 Two other biocompatible polymers that are commonly used for developing hydrogels are 
PHEMA and PVA. Even though PVA is a biodegradable polymer with good mechanical properties in the 
dry state, its highly hydrophilic properties decrease the mechanical stability in the wet state.44 Moreover, 
many of the agents (i.e. glutaraldehyde, succinyl chloride) used for chemical cross-linking are cytotoxic, 
therefore limiting the biomedical applications or requiring laborious purification procedures.11, 45 
PHEMA, has many advantages over other hydrogels such as: a water-content similar to living tissue, 
permeability to metabolites, resistance to absorption by the body and good optical transparency.1 
However, PHEMA hydrogels are nondegradable in vivo, and their application in areas like tissue 
engineering has been restricted. Compared to the before mentioned polymers, the PAOx were more 
recently employed to develop hydrogel materials for biomedical applications.37, 46 They can be regarded 
as interesting new hydrogels for biomedical applications, as PAOx exhibit good biocompatibility, 
hydrophilicity, and enable orthogonal functionalization possibilities, which has been well documented in 
recent years.18, 35, 37, 47-52 
Nevertheless, up to date there is no polymer that fulfills all the requirements for an ideal hydrogel with 
respect to its chemical nature, biocompatibility and biodegradability, and the chemical bond forming 
events to create covalent cross-links. Consequently, finding and investigating other alternative polymers 
represent the focus of the ongoing research. 
2-Isopropenyl-2-oxazoline (iPOx) is a monomer belonging to the 2-oxazolines class, which via its 
2-vinyl substituent can be polymerized to poly(2-isopropenyl-2-oxazoline) (PiPOx),53-55 with the retention 
of the 2-oxazoline ring as reactive side-chain functionality. Note that cationic ring-opening polymerization 
of iPOx is not possible due to interference of the isopropenyl group causing side reactions.56 PiPOx is a 
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versatile functional polymer as demonstrated in our recent reports53, 57, 58 due to the following reasons: i) 
PiPOx is highly hydrophilic, ii) is chemically inert to moisture and oxygen during storage, iii) is a 
functional polymer which can be prepared with well-defined characteristics by several living and 
controlled polymerization techniques,53, 59-61 iv) the ring opening addition of the oxazoline side-chain 
functionalities requires simple post-modification reaction conditions,53, 57, 58 v) no catalysts are needed for 
the polymer analogous reaction, vi) no by-products are produced when reacted with carboxylic acids,53, 
57, 58, 62 and vii) is biocompatible.62 Even though these characteristics make PiPOx highly appealing for 
the development of hydrogels for biomedical applications, to date there are no reports regarding PiPOx’s 
potential to be used as basis for the development of chemically cross-linked hydrogels. However, to ideally 
meet the requirements for usage in biomedical applications, in general, hydrogels need to: i) possess 
readily tunable hydrophilicity, ii) have a highly reproducible composition via synthesis (functionalization 
or cross-linking degree), iii) exhibit biocompatibility and degradability, whereas the degradation products 
should be non-toxic; and iv) should have good mechanical properties in order to be processed and 
manipulated. 
 To tackle these aspects, we elaborated a two-step synthesis procedure to obtain hydrogels based 
on PiPOx. First we prepared a well-defined PiPOx with controlled molar mass and narrow molar mass 
distribution via anionic polymerization, following our latest optimized conditions53 (see Scheme 1). Then, 
we used the highly effective ring-opening addition reaction of the pendant iPOx rings with several non-
toxic and bio-based dicarboxylic acids and prepared eight hydrogel series with different chemical 
compositions (see Scheme 1). Using this PiPOx post-polymerization modification approach, which was 
well documented in our group for soluble polymers,53, 57, 58, 63 we ensure reproducible synthesis at any 
stage of the hydrogel preparation. Another advantage of this approach is that we can control the quantity 
of ester-amide cross-links generated during the post-modification reactions, in order to preserve the 
balance between hydrophilic character vs. structural integrity of the final hydrogels. Moreover, the ester-
amide cross-links generated by the ring opening addition, are susceptible towards degradation at basic and 
acidic pH values, and possibly to enzymatic degradation in in vivo environments.64 
Thus, the present study aims to demonstrate that PiPOx represents a new versatile polymeric 
platform providing facile access to hydrogel materials with tunable water uptake. The hydrogels with 
highest water uptake are further investigated as thermoresponsive and side-chain degradable materials in 
simulated physiological buffer at different pH values. Preliminary investigations are carried out to 
5 
 
evaluate the cytotoxicity, protein absorption and mineralization of these new materials. In addition, the 
potential of this hydrogels to be used in drug-delivery applications is addressed. 
 
 
Scheme 1. Schematic representation of the reaction path to obtain PiPOx based hydrogels by cross-linking 
with dicarboxylic acids. 
 
2. RESULTS AND DISCUSSIONS 
 
2.1. Synthesis and characterization of the PiPOx hydrogels 
 To obtain cross-linked materials with tailored properties it is essential to control the chemical 
structure, dispersity and topology of the polymer. To ensure a high structural homogeneity of the 
hydrogels as well as reproducible properties and improved mechanical stability a well-defined polymer is 
needed. Therefore, making use of our recent optimized recipe for living anionic polymerization using 
commercially available n-BuLi,53 we synthesized a well-defined PiPOx homopolymer with a controlled 
number average molar mass of 10,600 g/mol and a dispersity of 1.17 as determined by SEC with multi 
angle light scattering detector. 
 The cross-linked PiPOx networks were successfully obtained by reacting the side-chain 2-
oxazoline groups with 8 different dicarboxylic acids under catalyst free conditions in N,N’-
dimethylacetamide (DMAc) at 140 °C. The reaction temperature was chosen according to our previous 
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studies regarding the ring opening addition reaction of PiPOx with different monocarboxylic acid to 
ensure a quantitative conversion of the 2-oxazoline rings and an optimum reaction time.53, 58 
 FT-IR analysis was used to investigate the chemical structure of the dry polymer networks. The 
FT-IR spectrum of PiPOx displayed the characteristic signals of the 2-oxazoline ring at 1648 cm-1 (C=N 
stretching) and 1121 cm-1 (C-O stretching) (see Fig S1). When the 2-oxazoline ring reacts with the acid, 
an ester–amide structure is generated (see Scheme 1). After cross-linking the signal corresponding to the 
carbonyl stretching vibration of the newly generated ester can be found at 1730 cm-1 (υC=O) (see Fig S1). 
In addition, although the carbonyl stretching vibration of the amide I band (υC=O) at 1648 cm−1 overlaps 
with the −C=N vibration of the 2-oxazoline ring, the amide II band appears as a distinct shoulder at 1530 
cm-1 (υC-N). The FT-IR data shows the successful modification reaction and revealed that all dry polymer 
networks have the same characteristic signals regardless of the cross-linker length (see Fig S1). 
 
2.2. Effect of reaction parameters on the hydrogel swelling ability 
 The synthesis of hydrogels using the post-polymerization modification reaction of PiPOx emerges 
as an appealing chemical strategy due to several important advantages: i) biocompatibility of the starting 
polymer,62 ii) low toxicity of the bio-based dicarboxylic acids, especially the ones with longer alkyl chain 
(azelaic and dodecanedioic acid), iii) absence of catalyst and by-products, iv) reduce reaction time and v) 
the reaction is quantitative at 140 °C. Finally, due to its versatility and robustness an entire library of 
hydrogels with tunable swelling behavior can effortlessly be obtained. The biomedical applications are 
predetermined by the capacity of hydrogels to absorb water. Therefore, since no literature studies could 
be found related to these materials we made a preliminary synthesis screening in which we investigated 
the influence of the following factors: (i) polymer concentration, (ii) molar ratio between the carboxylic 
acid (COOH) and 2-oxazoline (iPOx) groups; and (iii) chain length of the cross-linker on the equilibrium 
swelling degree (ESD) of the hydrogels. The swelling degree of the hydrogels in distilled water was 
measured at 20 °C and calculated using equation S1, which is summarized in Table 1. 
 The hydrogels were synthesized at four different polymer concentrations in DMAc: 10, 15, 20 and 
25 wt%. Equilibrium swelling degrees are obtained within 48 h, and, as expected, are dependent on the 
polymer concentration in the feed. In the case of 10 wt% polymer concentration, bulk hydrogels could not 
be obtained, regardless of the acid that was used or the COOH/iPOx molar ratio. However, we noticed an 
increase in the solution viscosity, probably due to mostly intramolecular reactions in combination with 
partial intermolecular coupling. At 15 wt% PiPOx and a 0.075 molar ratio of COOH/iPOx also no 
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hydrogels could be obtained, whatever the acid used. However, the longer dicarboxylic acids yielded 
hydrogels at 15 wt% from 0.1 molar ratio of COOH/iPOx while the shorter succinic acid did not result in 
hydrogels at 15 wt% at all. When using succinic acid as cross-linker, the first stable hydrogel (i.e. a 
hydrogel that can be cut into pieces, maintains its shape, is not sticky, and can be manipulated without 
breaking) was only obtained at 20 wt% PiPOx and 0.1 mole ratio COOH/ iPOx. The lower ability of 
succinic acid to form hydrogels with PiPOx may be ascribed to its shorter chain length, possibly favoring 
intramolecular coupling over intermolecular chain coupling. This hypothesis is confirmed by the fact that 
we initially also included the first two members of the dicarboxylic acid series (i.e. oxalic and malonic 
acid) in our studies. However, no shape stable hydrogels could be obtained even when the COOH/iPOx 
ratio was increased to 0.25 at 25 wt% polymer concentration. Therefore, in order to determine the structure 
of the formed material we removed the solvent, followed by washing the material with water and drying. 
FT-IR analysis revealed the same characteristic signals (see Fig. S2) as for the other hydrogels, which in 
combination with the inability to form hydrogels confirms that the coupling reaction mainly takes place 
intramolecularly due to the short chain length of the carboxylic acid. 
 From Table 1, one can notice that the ESD is higher at lower polymer concentration regardless of 
the cross-linker length, due to the formation of a more flexible network with lower cross-linking density. 
These results are in accordance with previous reports regarding the preferred formation of intramolecular 
loops at low reactant concentration.65 Furthermore, the ESD of the hydrogels decreased with increasing 
COOH/iPOx molar ratio (0.075, 0.1, and 0.125), irrespective of the acid used as the cross-linker, (Table 
1). This behavior can be explained by the fact that higher amounts of dicarboxylic acid lead to more cross-
linked structures, which absorbs less water. Finally, the modification of the dicarboxylic acid chain length 
can have two opposite effects on ESD of hydrogels. Using an acid with a higher number of carbon atoms 
should increase the hydrophobic character of the hydrogel leading to a lower water uptake, while the cross-
linking density should decrease generating a higher water absorption. The experimental results for the 
ESD demonstrated that the decrease in the cross-linking density predominates over the increase in the 
hydrophobic character especially in the case of longer chain acids (azelaic and dodecanedioic acid), whose 
water solubility is lower (Table 1). 
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Table 1. The equilibrium swelling degree (ESD) of the hydrogel series, in distilled water at 20 oC. 
Reported values are the mean of duplicate experiments provided with standard error. 
Acid 
Name 
nCOOH:niPOx 
 
 
 
 
Polymer 
Conc. 
(wt%) 
0.075 0.1 0.125 
 Acid 
Name 
nCOOH:niPOx 
 
 
 
 
Polymer 
Conc. 
(wt%) 
0.075 0.1 0.125 
C
o
m
m
o
n
 
IU
P
A
C
 
C
o
m
m
o
n
 
IU
P
A
C
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 10 - - - 
 
G
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c 
P
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10 - - - 
15 - - - 15 - 390±2 319±2 
20 - 
H4 
350±2 
 
257±4 
20 
H5 
420±3 
 
376±3 
 
312±4 
25 364±3 294±2 238±3 25 388±3 343±2 267±4 
A
d
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ic
 
H
ex
a
n
ed
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ic
 10 - - - 
P
im
el
ic
 
H
ep
ta
n
ed
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ic
 10 - - - 
15 - 343±5 311±4 15 - 438±5 344±3 
20 
H6 
364±2 
 
321±4 
 
291±3 
20 
H7 
506±2 
 
416±4 
 
313±5 
25 334±2 245±3 256±5 25 444±3 396±2 283±4 
S
u
b
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ic
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n
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 10 - - - 
A
ze
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ic
 
N
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n
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n
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 10 - - - 
15 - 395±4 316±2 15 - 589±5 467±3 
20 
H8 
426±2 
 
380±3 
 
300±2 
20 
H9 
675±1 
 
522±5 
 
425±4 
25 400±1 365±4 275±3 25 600±5 485±4 315±3 
S
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a
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c 
D
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a
n
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 10 - - - 
- 
D
o
d
ec
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10 - - - 
15 - 422±5 345±2 15 - 608±5 470±4 
20 
H10 
464±1 
 
413±4 
 
331±4 
20 
H12 
732±3 
 
555±4 
 
431±2 
25 431±4 377±3 300±1 25 620±2 509±3 320±5 
 
 In conclusion for this part, the hydrogel screening study proved that the ESD can be easily and 
accurately tuned by controlling the three parameters: polymer concentration, COOH/iPOx molar ratio and 
chain length of the cross-linker, therefore paving the way for different applications from tissue engineering 
to ocular lenses that all require hydrogels with different water content. 
 Based on these data, a selection of the most promising materials for further investigations could 
be made. It is well known that hydrogels with higher water uptake are expected to release higher amounts 
of solutes and have a more pronounced pH-degradability.66 Therefore, the hydrogels with the highest ESD 
in their corresponding class, namely H4, H5, H6, H7, H8, H9, H10 and H12, were selected for further 
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investigations. The conditions for these hydrogel preparations are 20 wt% polymer concentration and 
0.075 mol ratio of COOH/iPOx, except for the succinic acid where the first stable hydrogel was obtained 
for 0.1 mol ratio of COOH/iPOx. Accordingly, we further investigated the network parameters, 
thermoresponsive behavior, and stability in simulated physiological fluids at different pH values of these 
hydrogels. 
 
2.3. Hydrogel network structure and odd-even effect 
 In a next step, we examined the effect of the number of carbon atoms of the cross-linker on the 
network parameters, such as cross-linking density and mesh size as well as the ESD. From Table 2 it is 
evident that hydrogels cross-linked with dicarboxylic acids with an even number of carbon atoms have 
higher cross-linking density (ρc) except for H12. The mesh size (ξ) quantifies the distance between two 
adjacent cross-links and it is a critical parameter in controlling the drug diffusion rate as it reflects the 
amount of space available for a drug molecule to diffuse in or out of the swollen hydrogel network. 
Obviously, the mesh size follows the opposite trend of cross-linking density (i.e. the more cross-linked a 
hydrogel is the lower the mesh size). 
 
Table 2. Network parameters for H4-H12 hydrogels. 
Code Number of  
carbon atoms 
?̅?𝒄 (𝐃𝐚)
a) ρc x 10-4 (mol/cm3)b) ξ (nm)c) 
H4 4 755.9 14.03 13.33 
H5 5 988.2 10.74 18.42 
H6 6 801.3 13.24 14.29 
H7 7 1278.7 8.30 25.59 
H8 8 1008.4 10.52 18.89 
H9 9 1837.3 5.78 42.41 
H10 10 1138.6 9.32 22.02 
H12 12 2012.6 5.27 48.72 
a) average molecular weight between cross-links, calculated with equation S2 
b) cross-linking density calculated with equation S4 
c) mesh size calculated with equation S5 
 
 Consequently, the hydrogels cross-linked with dicarboxylic acids with even numbers of carbon 
atoms have lower ESD with respect to their odd analogs (Fig. 1). This effect can be probably assigned to 
a higher amount of cyclic defects present in the network of hydrogels crosslinked with odd dicarboxylic 
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acids as previously reported by Olsen for polymer networks prepared via end-linking reactions.67 Using 
Monte Carlo simulation, they demonstrated an odd−even alternation of the loop densities on the junction 
functionality, which results from the topological constraint of the network. Even though the present 
hydrogels are not synthesized by end-linking coupling of polymeric precursor the same mechanism could 
operate also in our case. Consequently, the hydrogels cross-linked with dicarboxylic acids having odd 
numbers of carbon atoms have a lower crosslinking density due to the higher number of loops resulting in 
a higher ESD, as observed. Another noteworthy aspect is the notable increase of the ESD from 420% (H5) 
to 675% (H9) registered in the case of odd alkyl ester amide hydrogels (see Table 1 and Fig. 1). While for 
the hydrogels with an even number of atoms the increase is shallow going from 350% (H4) to 464% 
(H10). However, the hydrogels cross-linked with dodecanedioic acid, having also an even number of 
carbon atoms, exhibited the highest ESD from the series. This occurrence can be explained by the lower 
crosslinking density of the hydrogel (i.e. higher ξ, see Table 2) due to increase flexibility of the cross-
linker chain therefore producing a higher water absorption. Another aspect could be related to an increased 
probability to participate in intramolecular reactions because of the increased flexibility of the chain. 
 
 
Figure 1. ESD dependence of the on the number of dicarboxylic carbon atoms in distilled water at 20 °C 
for the hydrogels (H4-H12). Reported values are the average of duplicate experiments. 
 
2.4. Thermoresponsive properties of the H4-H12 hydrogels 
 In a recent study, we demonstrated that PiPOx can be chemically modified with mono carboxylic 
acids yielding soluble thermoresponsive polymers.53, 63 Modulation of the cloud point temperature was 
achieved by controlling the modification degree and/or by changing the hydrophobic character of the acid. 
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Consequently, it may be expected that PiPOx based hydrogels containing longer hydrophobic ester amide 
chains to exhibit a volume-phase transition temperature (VPTT). The thermoresponsive behavior of the 
H4-H12 hydrogels was investigated by measuring their ESD at different temperatures. The temperature 
sweep experiments were carried out within the 20 °C – 70 °C range. The ESD only slightly decreased in 
a continuous manner with increasing temperature for H4-H8 hydrogels indicating the absence of a VPTT 
(see Fig. 2). The slight decrease in water absorption with increasing temperature is a general phenomenon 
for hydrogels as the chain flexibility increases and the water-polymer interactions decrease. A more 
pronounced and abrupt decrease of ESD with temperature was noticed for H9 and H10 due to the 
increasing hydrophobic character of the dicarboxylic acid (see Fig. 2). However, the use of dodecanedioic 
acid led to a truly thermosensitive hydrogel with a VPTT of 43 °C (see Fig. 2). The larger transition 
interval may be ascribed to the random distribution of relatively large hydrophobic units,68 by comparison 
with other thermosensitive hydrogels, such as poly(N-isopropylacrylamide)69 or poly(N-
vinylcaprolactam),70 with smaller more evenly distributed hydrophobic domains that have a discontinuous 
volume phase transition, namely a narrow VPTT interval. However, increasing the content of acid, could 
lead to a VPTT close to body temperature and a narrow temperature transition with potential application 
in drug delivery, which is currently under investigation. 
 
 
Figure 2. ESD dependence on temperature for the hydrogels (H4-H12) cross-linked with different 
dicarboxylic acids. Reported values are the average of duplicate experiments. The digital photos show the 
changes in transparency with temperature for the H12 hydrogel. 
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2.5. Stability in simulated physiological fluids 
 To demonstrate the stability of the hydrogels at pH 7.4, the samples were incubated in phosphate 
buffered saline (PBS) solution at 37 °C. The swelling ratios were calculated using equation (S1). The time 
needed for the hydrogels to reach the equilibrium swelling degree was similar for both water and PBS 
media, namely 48 hours (see Fig. 3) with a steady SD and dimensional stability over a 14-day period. 
Slightly lower ESD values were obtained in PBS compared to water, due to the presence of sodium 
chloride that has a salting out effect. However, the general odd-even trend is preserved in the H4-H12 
series in PBS (see Fig S3). 
 
 
Figure 3. (a) Swelling degree versus time plots for the H4-H12 gels in PBS (pH 7.4) at 37 °C. Inset shows 
the swelling degree as a function of time for the first 5 h and (b) ESD dependence on saline solution 
concentration at 37 °C for the hydrogels (H4-H12). Reported values are the average of duplicate 
experiments. 
 
 In the view of biomedical applications, we tested also the swelling behavior of the H4-H12 gels in 
saline solutions. We choose two different concentrations of sodium chloride, namely 9 mg/mL and 30 
mg/mL corresponding to normal physiological saline solution and hypertonic saline, respectively. The 
results demonstrated that the presence of a salt in the swelling medium decreased the ESD of the H4-H12 
hydrogels as compared to the results obtained in PBS (see Fig. 3b). The lower ESD can be ascribed to the 
salting out effect induced by the higher concentration of salting out ions compared to PBS. The ESD 
decrease was situated between 10% and 14% for H5-H10 gels, while the H4 and H12 hydrogels revealed 
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a reduction of 22.4% and 19.5%, respectively. Furthermore, the ESD was even lower for more 
concentrated salt solutions for all hydrogels (see Fig. 3a). 
 As previously stated, PiPOx hydrogels are designed to be susceptible to hydrolytic side-chain 
degradation through the ester bonds. The hydrolysis should lead to low-molecular weight products with 
low toxicity (i.e. dicarboxylic acids) and the generation of a soluble poly(2-isopropenyl-2-oxazoline-co-
N-(2-hydroxyethyl)methacrylamide) (co)polymer. The hydrolyzed moiety has a similar structure to 
poly(N-(2-hydroxypropyl) methacrylamide) (PHPMA), which is known to be biocompatible.71 
Consequently, one may assume that if the molar mass of the starting PiPOx is lower than ~ 40,000 g/mol 
the resulting polymer could be excreted by renal filtration process.72 Therefore, the hydrolytic stability of 
the hydrogels was tested in two different buffer solutions with pH values of 3 and 11, respectively 
according to Mandal’s protocol.73 Surprisingly, the water absorption of the hydrogels was lower at pH 3 
than at pH 7.4 irrespective of the cross-linker length (see Fig. 4a). For H4-H10 approximately a 1.3 fold 
decrease of the SD was registered in 24 h. The highest difference in the SD of ~ 1.6 fold lower was 
measured for H12. Moreover, the SD continuously decreased with time (see Fig 4a), although an opposite 
behavior was anticipated due to the cleavage of the ester bond. This anomalous behavior can be explained 
by the acid-catalyzed cross-linking of unreacted 2-oxazoline side chains, which lead to an increase in 
cross-linking density as illustrated in Scheme S1. The mechanism for this cross-linking is similar to that 
for the cationic ring opening polymerization of 2-oxazolines.48 Initial protonation of a pendant 2-oxazoline 
moiety generates an electrophilic site that may be attacked by the nucleophilic nitrogen of a neighboring 
2-oxazoline ring, rapidly creating a ring-opened polymer network. To get more insight on the structure of 
the network formation on pH 3 we removed the H12 hydrogel after 14 days of incubation washed it with 
distilled water and dried it. The FT-IR spectrum of the dry polymer network shows a decrease of the band 
at 1730 cm-1 compared to the gel incubated at pH 7.4 proving that the cleavage of the ester takes place 
(Fig. S4). A closer inspection of the spectrum reveals a broadening of the band at 1650 cm-1 and the 
appearance of a new band at 1056 cm-1, corresponding to the newly formed cross-linked structure as 
proposed in Scheme S1. For comparison and clarity, we showed in Fig S4 also the spectra of the poly(2-
ethyl-2-oxazoline) obtained by cationic ring opening polymerization, which has a similar structure with 
the newly generated network. The ester hydrolysis was counterbalanced by the supplementary induced 
cross-linking of the iPOx unreactive groups, resulting in hydrogels which maintained their structural 
integrity (see Fig. S4 right photo). However, we cannot completely overrule the possibility of 2-oxazoline 
hydrolysis at this acidic pH, which would generate a poly(methacrylic acid) copolymer. Ultimately this 
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would also lead to a decrease in the ESD because the carboxyl groups are protonated at pH 3. In view of 
these results, the side-chain degradability of soluble polymers will be a focus of our future work. This 
behavior can be further exploited for the synthesis of pH sensitive hydrogels.  
 At basic pH the SD continuously increased with time in the studied interval for all hydrogels. A 
higher water absorption, and in some cases, the complete dissolution of the hydrogel (H5-H9) into the 
incubation medium was registered due the ester bond cleavage leading to loss of the cross-links. Hydrogels 
that are cross-linked with acids that have an odd number of carbon atoms in the linker degraded much 
more rapidly and to a greater extent than the ones with even carbon atoms (see Fig 4b H7 and H9), except 
H5. One possible explanation for the faster degradation of H7 and H9 as compared to H5 could be their 
higher water absorption that increases the hydrolysis rate (hence the side-chain degradation). The 
increased stability of H10 and H12 hydrogels can be attributed to the hydrophobic shielding of the ester 
groups by the increase number of methylene units present in the crosslinker, thereby lowering the 
hydrolysis rate (Fig. S4 right photo). The SD of the H4 hydrogel increased with time while no 
fragmentation or dissolution was detected due to the higher cross-linking degree (see Table 1) as compared 
with the other hydrogels. Although at pH 11 the hydrolysis of both amide and ester bond can occur, the 
FT-IR spectra proved that only cleavage of the ester is taking place. The intensity of the 1730 cm-1 band, 
corresponding to the C=O ester vibration is reduced compared with the one in the starting dry network, 
while the amide II band (1530 cm-1) increases slightly and shifts to higher wavenumbers, probably due to 
the presence of salts from PBS (see Fig S4).  
 
 
Figure 4. Swelling degree–time plots for the H4-H12 gels in PBS at 37 °C: (a) pH 3 and (b) pH 11. 
Reported values are the average of duplicate experiments. 
15 
 
 
2.6. Analysis of the swelling process 
 For drug delivery applications, not only the swelling degree is important, but also the swelling rate 
as this may influence how fast a drug can be absorbed or released. Therefore, we investigated the 
mechanism of water transport and the swelling kinetics within the H4-H12 gels in PBS at 37 °C. The 
swelling process of hydrogels can be divided into two molecular processes: penetration of the solvent 
molecules into the void spaces in the network and subsequent relaxation of the polymeric chains. The 
process can be analyzed by the Fickian diﬀusion model and the Schott’s second-order-kinetic model, 
respectively. To determine the mechanism of water diffusion through the hydrogel in the initial swelling 
state, equation 1 was employed, considering only the data fulfilling the condition SDt/ESD ≤ 0.6.74 
𝑀𝑡
𝑀∞
=
𝑆𝐷𝑡
𝐸𝑆𝐷
= 𝑘 ∙ 𝑡𝑛           (1) 
Where Mt and M∞ represents the amount of water absorbed at time t (min) and at equilibrium, respectively, 
k is a constant depending on the characteristics of both gel and solvent, while n is the swelling exponent, 
indicating the diffusion mechanism. The constants k and n were determined from the intercept (logk) and 
slope (n) of the log(SDt/ESD) vs. log(t) plots (Fig. S5a). Depending on the relative rates of diffusion and 
polymer relaxation, three mechanism of diffusion can be distinguished for disk shape samples: i) Fickian 
diffusion mechanism (Case I) when n = 0.5, ii) non-Fickian (anomalous) diffusion mechanism for 0.5 < n 
> 1 and finally iii) Case II diffusion mechanism when n = 1. 
 The calculated values for k and n are given in Table 3. For H4 - H8 hydrogels the swelling exponent 
was larger than 0.5 supporting the anomalous transport mechanism, i.e. the water uptake is controlled 
collaboratively by water diﬀusion and relaxation of the polymeric network. While the swelling mechanism 
of the H9-H12 hydrogels changes to diffusion controlled meaning that the water diffusion rate is much 
lower than polymer relaxation. This further suggests that the hydrogels cross-linked with longer alkyl 
chain dicarboxylic acids have a more flexible structure because of the lower cross-linking density. 
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Table 3. Swelling kinetic parameters for H4-H12 hydrogels in PBS at 37 °C. 
 Fickian diffusion model Schott’s second order kinetic model 
Code n k∙102 R2 Diffusion mechanism ESDexp 
(g/g) 
ESDcalc 
(g/g) 
K∙103 
g/(g∙min) 
R2 
H4 0.529 10.35 0.9935 Anomalous 3.18 3.12 12.19 0.9989 
H5 0.510 15.49 0.9921 Anomalous 3.85 3.86 23.43 0.9999 
H6 0.616 9.42 0.9943 Anomalous 3.54 3.49 22.82 0.9990 
H7 0.533 8.62 0.9953 Anomalous 4.15 4.13 7.26 0.9999 
H8 0.518 5.98 0.9986 Anomalous 3.90 3.83 4.84 0.9997 
H9 0.437 8.39 0.9989 Fickian 5.02 4.94 4.18 0.9979 
H10 0.416 9.90 0.9936 Fickian 4.17 4.20 4.74 0.9991 
H12 0.402 12.41 0.9952 Fickian 6.26 6.22 5.30 0.9994 
 
 To have an overall assessment of the diffusion mechanism during the entire swelling period, the 
Schott’s second-order kinetic model must be used and it can be described using equation 2.75 
𝑡
𝑆𝐷𝑡
=
1
𝐾∙𝐸𝑆𝐷2
+
𝑡
𝐸𝑆𝐷
          (2) 
Where SDt (g/g) and ESD (g/g) are the swelling degree at time t (min) and the equilibrium swelling degree, 
respectively; K (g/g·min) is the swelling rate constant. 
 The plots of t/SDt versus time revealed perfect straight lines (Fig. S5b) with very good linear 
correlation coeﬃcient (R2 >0.99, Table 3) for all hydrogels, thus confirming that the Schott’s second-
order-kinetic model can be eﬀectively applied for describing the entire swelling process. The equilibrium 
swelling degrees (ESDcalc) determined from the plots, agreed very well with less than 2% error with the 
experimentally measured (ESDexp) (see Table 3). Analyzing the data in Table 3 we can observe that the K 
constant is larger for the hydrogels cross-linked with shorter carboxylic acids (H4-H6) that have higher 
hydrophilicity. The lower value found in the case of H4 can be explained by the higher degree of cross-
linking (10 mol% COOH/iPOx) which slows down the water diffusion process. For hydrogels cross-linked 
with longer alkyl chains dicarboxylic acids, the K constant is approximately 4 times lower and starts to 
level off, thus accounting for the increased hydrophobic character of the cross-linker. 
 
2.7. In vitro release of drugs 
 The potential of the PiPOx hydrogels for drug delivery was preliminarily assessed using two 
different hydrophilic model drugs: 5-fluorouracyl (5-FU) and sodium diclofenac (DCFNa). DCFNa is a 
larger molecule than 5-FU and is also able to form hydrophobic interactions as well as hydrogen bonds, 
while 5-FU can form stronger hydrogen bonding but the capacity to form hydrophobic interactions is 
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reduced. Moreover, two different hydrogels were chosen for these tests, H4 and H9, which we expected 
to interact in a different manner with the drugs resulting from the large difference in dicarboxylic acid 
chain length. The amount of drug released was determined by UV–Vis spectroscopy and calculated from 
the corresponding calibration curve prepared using standard solutions of known concentrations according 
to literature.76 
 The drug release experiments revealed a much higher release rate in the case of 5FU (Fig. 5), 
despite that the hydrogels had different mesh sizes (H4, ξ = 13.3 nm and H9, ξ = 42.4 nm). One can 
conclude that the polymeric network interacts stronger with the DCFNa and a prolonged release is 
obtained. This behavior could be ascribed to the lower molecular size of 5FU and the reduced ability to 
form hydrophobic interactions. However, regardless of the drug used, the hydrogel H9 with a higher mesh 
size revealed slower drug release indicating that the hydrophobic interactions between the drug and the 
polymer network are more important for the release rate of small molecule drugs than the mesh size. 
Finally, the data suggests that a variable drug release rate can simply be obtained through variation of the 
cross-linker chain length. 
 
 
Figure 5. Influence of the dicarboxylic acid chain length on the in vitro release of: (a) 5-fluorouracyl 
(5FU) and (b) diclofenac sodium (DCFNa) in time. Data shown are averages of three release experiments. 
 
 Based on the cumulative release vs. time plots, the mass transport mechanism of the drug from the 
H4 and H9 hydrogels was analyzed by means of the Ritger–Peppas equation77 by considering only the 
data fulfilling the condition Mt/M∞ < 0.6. 
𝑀𝑡
𝑀∞
= 𝑘 ∙ 𝑡𝑛 (3) 
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Where Mt/M∞ is the fractional drug release after time t (min), while k and n are two constants, the exponent 
n being characteristic to the transport mechanism.  
 A linear correlation was found by plotting log(Mt/M∞) vs. log(t) and the slope of the lines was used 
to calculate the n value (Fig. S6). The n values for 5FU were lower than 0.5 thus indicating that the drug 
transport mechanism is influenced only by diffusion (Fig S6). On the contrary, for DCFNa an anomalous 
(non-Fickian) transport mechanism (0.5<n<1) was valid for both hydrogels (Fig S6). In this case the rates 
of drug diffusion and polymer relaxation were similar, and therefore both diffusion and gel swelling 
influenced the drug release. 
 
2.8. Direct cytotoxicity assay 
 An important argument that moves PiPOx polymer forward to a variety of biological applications, 
is the recent report by Kronek’s group concerning PiPOx’s biocompatibility.62 Consequently, we 
investigated the cytotoxic nature of PiPOx using MTT cytotoxicity assay to determine if there is any 
difference between the polymer obtained by radical (Kronek’s study) and anionic polymerization (present 
study). The cytotoxicity studies revealed that the non-toxic concentration for a cell viability higher than 
80% is 13.5 mg/mL after 24 h of incubation (Fig. S7a). The results obtained are similar with those reported 
by Kronek.62 Furthermore, we performed a cytotoxicity assay of the hydrogels to assess their use as 
potential biomaterials. For this test we used the hydrogel cross-linked with azelaic acid. Culturing the 
L929 murine fibroblast cells on the hydrogel for 1-day led to a similar viability when compared to tissue 
culture plates surface, as seen in Figure S7b. No significant difference was found (p > 0.6) confirming the 
high potential of this hydrogel for further investigations as biomaterial. 
 
2.9. Protein adsorption 
 Next, we investigated the preliminary protein resistivity of the H9 hydrogel, at one model protein, 
BSA, since azelaic acid is a naturally occurring dicarboxylic acid that has antimicrobial activity and 
decreases hyperkeratosis, and has also been used for topical applications.78 The ability to repel proteins 
within aqueous environments would be extremely beneficial preventing many undesired polymer-cell and 
polymer-microorganism interactions, known as anti-fouling behavior. The amount of protein adsorption 
from 0.5 mg/ml BSA and 1 mg/ml BSA solutions was very small, close to the detection limit for the 
Coomassie colloidal blue G250 staining. The desorbed protein from 3 mg/ml BSA was estimated at 2.3 ± 
0.2 µg/cm2 hydrogel. Therefore, we can conclude that the investigated hydrogel releases a small amount 
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of protein during 24h, under a static experiment and consequently one may indirectly assume that it has 
high protein adsorption resistance. This aspect is extremely beneficial for further developing hydrogel 
coatings for, e.g., stent applications with both drug release and protein adsorption resistance, and for ocular 
applications such as contact or intraocular lenses. However, advanced investigation of different types of 
proteins, similar to adhesion cell complex and bacterial adhesion and growth is further required to 
elucidate the eventual protein resistance potential of such hydrogels Future work will also cover 
investigations in these directions as well as in-depth investigation of the interaction of the hydrogel with 
other types of proteins. 
 
2.10. Mineralization studies 
 The H9 hydrogel showed very good optical transparency in the visible spectral range (Fig. S8), 
and because diclofenac is used to treat inflammation of the eye after cataract or corneal refractive 
surgery,79 H9 could potentially be used for ocular drug delivery applications. According to such potential 
use, it becomes of uttermost importance to screen the stability of the hydrogel with respect to 
mineralization phenomena in physiological conditions. Therefore, preliminary mineralization studies of 
the hydrogels obtained using azelaic acid (H9) have been performed to investigate its behavior in synthetic 
body fluid (SBF). SEM investigation indicated that the surface morphology typical to amorphous samples 
did not change after incubation in SBF and no mineral phase was identified on the samples even after 21 
days (Fig. 6). Such behavior clearly indicates that the hydrogel does not promote mineralization 
phenomena. This was also confirmed by EDX analysis, in which no mineral phase (containing calcium of 
phosphorus) has been detected on the surface of the samples after incubation in SBF. This is an important 
indication for the potential use of such scaffolds as implantable biomaterials not promoting 
mineralization/calcification phenomena such is the case of intraocular lenses or devices. 
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Figure 6. SEM micrographs relevant for the surface of the hydrogel after incubation in SBF: a) after 7 
days incubation, b) after 14 days, c) after 21 days. No calcification, no surface fractures nor degradation 
were noticed after the established time intervals. 
 
3. CONCLUSIONS 
Novel hydrogels with tunable water uptake were developed using a simple yet robust synthetic strategy 
by cross-linking a well-defined PiPOx polymer with different dicarboxylic acids. The ESD could be easily 
tailored by varying the polymer concentration, the length of the cross-linker and/or the COOH/iPOx molar 
ratio. Swelling studies reveal that the ESD shows an odd-even alternation as a function of the cross-linker 
length. The polymer gels with odd alkyl ester amide chains have a looser interlayer packing allowing the 
water molecules to reside between the chains. The hydrogels displayed temperature sensitivity in water 
and also pH side-chain degradability, when tested in simulated physiological fluids. Hydrogel H12 cross-
linked with dodecanedioic acid displayed a VPTT of 43 °C. The analysis of the swelling process in PBS 
at pH 7.4 clearly indicated a dependence of diffusion mechanism on the cross-linker length. The swelling 
exponent was below 0.5 for the hydrogels cross-linked with longer chain dicarboxylic acids, pointing to a 
Fickian transport mechanism. Moreover, water penetration into the hydrogel followed second-order 
kinetics, with the swelling rate constant K decreasing with the increase of the cross-linker length. The rate 
of drug release at pH 7.4 was affected mainly by drug–hydrogel network interactions since the more 
hydrophobic DCFNa was released much slower than 5FU. The release rate of both drugs was dependent 
on the hydrophobicity of the cross-linker. An anomalous (non-Fickian) transport mechanism was 
evidenced in the case of DCFNa release, while for 5FU the release was controlled only by the diffusion, 
i.e. Fickian transport mechanism. In vitro cytotoxicity measurements and protein adsorption study 
demonstrate the non-cytotoxic character of PiPOx hydrogels, and low preliminary adhesion to BSA. The 
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mineralization studies showed that PiPOx hydrogel do not promote the mineralization/calcification 
phenomena. 
This work opens new avenues towards developing smart drug delivery systems, make use of the 
thermosensitivity of the PiPOx hydrogels, and in ophthalmology based on its very good optical 
transparency and tunable ESD. Future work will also cover investigations on enzymatic degradability of 
the here reported hydrogels, mechanical testing, as well as the advanced monitoring of their protein 
interactions. 
 
Supporting information available: The supporting material contains the experimental section, Scheme 
S1 and the supporting Figures S1-S8. 
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